Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Consulting agrmnt
Director departure
Appointed director
|
|
180 Life Sciences Corp. (KBLM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 09/28/2023 |
8-K
| Quarterly results |
| 08/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"A.G.P./Alliance Global Partners 590 Madison Avenue, 28th Floor 10022",
"The Holder and any assignee, by acceptance of a Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face thereof.",
"AMENDMENT NO. 2 TO WARRANTS",
"WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.",
"Investor Contact:",
"Investor Contact:" |
|
| 08/07/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/03/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/31/2023 |
8-K
| Quarterly results |
| 07/10/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
8-K
| Quarterly results |
| 04/26/2023 |
8-K
| Quarterly results |
| 02/23/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 02/22/2023 |
8-K
| Investor presentation |
| 01/20/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/18/2023 |
8-K
| Quarterly results |
| 01/17/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/12/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 01/05/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/04/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 12/29/2022 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data|
Docs:
|
"THIRD AMENDMENT TO CONSULTANCY AGREEMENT This Third Amendment to Consultancy Agreement , dated December 28, 2022 , amends that certain Consultancy Agreement dated February 22, 2021 1 , amended by the First Amendment to Consultancy Agreement dated March 31, 2021 and effective as of December 1, 2020 2 and the Second Amendment to Consultancy Agreement dated April 27, 2022 3 , by and between 180 Life Sciences Corp., a Delaware corporation , Prof Jagdeep Nanchahal , and CannBioRex Pharma Limited, a subsidiary of the Company . Certain capitalized terms used below but not otherwise defined shall have the meanings given to such terms in the Consultancy Agreement. The Company and CannBioRex UK together shall also be referred to as the “Group Company.” WHEREAS, the Group Company and the Consultant d..." |
|
| 12/29/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 12/16/2022 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 11/30/2022 |
8-K
| Quarterly results |
| 11/15/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 10/04/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 09/26/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/22/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/27/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 07/19/2022 |
8-K
| Quarterly results |
| 06/22/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 06/14/2022 |
8-K
| Quarterly results |
| 05/26/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/28/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/14/2022 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events Interactive Data |
| 03/28/2022 |
8-K
| Other Events Interactive Data |
| 01/31/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
|
|
|